Meng Wei

462 total citations
22 papers, 242 citations indexed

About

Meng Wei is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Meng Wei has authored 22 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Meng Wei's work include Adrenal and Paraganglionic Tumors (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Ferroptosis and cancer prognosis (3 papers). Meng Wei is often cited by papers focused on Adrenal and Paraganglionic Tumors (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Ferroptosis and cancer prognosis (3 papers). Meng Wei collaborates with scholars based in China and United States. Meng Wei's co-authors include Run Yu, Deepti Dhall, Nicholas N. Nissen, Edward H Phillips, Feixiang Wu, Rong Liang, Yan Lin, Shan Li, Le‐Qun Li and Tao Bai and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and Frontiers in Microbiology.

In The Last Decade

Meng Wei

21 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng Wei China 9 80 68 66 45 35 22 242
Zhongwei Lv China 10 65 0.8× 62 0.9× 44 0.7× 21 0.5× 18 0.5× 27 274
Lianhua Li China 10 99 1.2× 169 2.5× 31 0.5× 56 1.2× 43 1.2× 24 357
Hongfeng Zhou China 10 130 1.6× 36 0.5× 43 0.7× 70 1.6× 20 0.6× 23 339
Nicolas Provost France 9 63 0.8× 51 0.8× 29 0.4× 18 0.4× 25 0.7× 17 257
Zhonghang Xu China 10 105 1.3× 23 0.3× 64 1.0× 30 0.7× 22 0.6× 20 339
Guibin Zheng China 10 68 0.8× 120 1.8× 139 2.1× 47 1.0× 18 0.5× 31 286
Katja Svennevig Norway 8 93 1.2× 61 0.9× 12 0.2× 50 1.1× 28 0.8× 9 295
Rosario Abellán Spain 12 80 1.0× 51 0.8× 97 1.5× 35 0.8× 8 0.2× 19 270
Liping Bai China 9 61 0.8× 41 0.6× 20 0.3× 16 0.4× 39 1.1× 21 245
Jason Farrow United States 6 80 1.0× 101 1.5× 63 1.0× 58 1.3× 8 0.2× 10 255

Countries citing papers authored by Meng Wei

Since Specialization
Citations

This map shows the geographic impact of Meng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Wei more than expected).

Fields of papers citing papers by Meng Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Wei. The network helps show where Meng Wei may publish in the future.

Co-authorship network of co-authors of Meng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Wei. A scholar is included among the top collaborators of Meng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Wei. Meng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Yuting, Rong Zhao, Lu Chen, et al.. (2025). Multi-omics assessment of gut microbiota in circadian rhythm disorders: a cross-sectional clinical study. Frontiers in Cellular and Infection Microbiology. 15. 1524987–1524987. 1 indexed citations
2.
Zhang, Yuxiang, Meng Wei, Lingling Xie, et al.. (2024). Comprehensive analysis of GINS subunit expression, prognostic value, and immune infiltration in clear cell renal cell carcinoma. Translational Andrology and Urology. 13(8). 1517–1536.
3.
Yang, Jing, Meng Wei, Xin Liu, et al.. (2023). PD‐L1 expression downregulation by RNF43 in gastric carcinoma enhances antitumour activity of T cells. Scandinavian Journal of Immunology. 97(6). e13268–e13268. 1 indexed citations
4.
Wei, Meng, et al.. (2023). Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy. World Journal of Gastroenterology. 29(21). 3280–3291. 4 indexed citations
5.
Huo, Kang, et al.. (2023). Solasonine ameliorates cerebral ischemia-reperfusion injury via suppressing TLR4/MyD88/NF-κB pathway and activating AMPK/Nrf2/HO-1 pathway. International Immunopharmacology. 124(Pt A). 110862–110862. 6 indexed citations
7.
Li, Siyu, Lu Chen, Zhifeng Xiao, et al.. (2023). The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease. Frontiers in Microbiology. 14. 1188455–1188455. 12 indexed citations
8.
Wei, Meng, Jialong Liu, Jingtong Zhai, et al.. (2022). Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation. Frontiers in Oncology. 12. 835603–835603. 15 indexed citations
10.
Wei, Meng, et al.. (2019). Clinical applicaton of three-dimensional visualization technology in hepatectomy of complex hepatocellular carcinoma. Zhonghua gan-dan waike zazhi. 25(9). 653–655. 1 indexed citations
11.
Ye, Jiazhou, Rong Liang, Tao Bai, et al.. (2018). RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 212–212. 46 indexed citations
12.
Ma, Jian, et al.. (2017). NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure. Medicine. 96(51). e9181–e9181. 23 indexed citations
13.
Wei, Meng, et al.. (2014). Insignificant Medium-Term Vitamin D Status Change after 25-Hydroxyvitamin D Testing in a Large Managed Care Population. PLoS ONE. 9(8). e105571–e105571. 7 indexed citations
14.
Lu, Zhigang, Bo Wang, Yunliang Wang, et al.. (2014). Relationship between CCR and NT-proBNP in Chinese HF Patients, and Their Correlations with Severity of HF. BioMed Research International. 2014. 1–7. 3 indexed citations
15.
Wei, Meng, et al.. (2013). Clinical utility of FDG-PET for diagnosis of adrenal mass: a large single-center experience. HORMONES. 12(3). 417–427. 8 indexed citations
16.
Yu, Run, et al.. (2012). Small Pheochromocytomas: Significance, Diagnosis, and Outcome. Journal of Clinical Hypertension. 14(5). 307–315. 11 indexed citations
17.
Yu, Run, et al.. (2008). Diagnosis and Treatment of Pheochromocytoma in an Academic Hospital from 1997 to 2007. The American Journal of Medicine. 122(1). 85–95. 42 indexed citations
18.
Yu, Run, Nicholas N. Nissen, Deepti Dhall, & Meng Wei. (2008). Pheochromocytoma in Patients Suspected of Harboring Adrenal Meta stasis: Management and Clinical Predictors. Endocrine Practice. 14(8). 967–972. 3 indexed citations
19.
Wei, Meng, Pengyuan Yang, Xing Zheng, et al.. (2007). REGULATION OF NOGO‐B EXPRESSION IN THE LESION OF AORTIC ANEURYSMS. Clinical and Experimental Pharmacology and Physiology. 34(9). 856–860. 8 indexed citations
20.
Wei, Meng, et al.. (1993). Determinations of 90 Sr, 137 Cs, 226 Ra, 228 Ra, 210 Pb, 210 Po contents in chinese diet and estimations of internal doses due to these radionuclides. 13(2). 85–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026